Sarek Shen

Dr. Sarek Shen

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SKSangwoo S. Kim
Sangwoo S. Kim
SSSarek Shen
Sarek Shen
SMSayuri Miyauchi
Sayuri Miyauchi
PSP. Dominick Sanders
P. Dominick Sanders
IFIda Franiak-Pietryga
Ida Franiak-Pietryga
ASAndrew B. Sharabi
Andrew B. Sharabi
Purpose: To characterize the role of B cells on human papilloma virus (HPV)-associated cancer patient outcomes and determine the effects of radiation and PD-1 blockade on B-cell populations.Experimental Design: Tumor RNA-sequencing data from over 800 patients with head and neck squamous cell carcinoma (HNSCC) and cervical cancer, including a prospective validation cohort, was analyzed to study the impact of B-cell gene expression on overall survival (OS). A novel murine model of HPV+ HNSCC was used to study the effects of PD-1 blockade and radiotherapy on B-cell activation, differentiation, and clonality including analysis by single-cell RNA-sequencing and B-cell receptor (BCR)-sequencing. Human protein microarray was then used to quantify B-cell–mediated IgG and IgM antibodies to over 16,000 proteins in the serum of patients treated on a clinical trial with PD-1 blockade.Results: RNA-sequencing identified CD19 and IGJ as novel B-cell prognostic biomarkers for 3-year OS (HR, 0.545; P < 0.001). PD-1 blockade and radiotherapy enhance development of memory B cells, plasma cells, and antigen-specific B cells. BCR-sequencing found that radiotherapy enhances B-cell clonality, decreases CDR3 length, and induces B-cell somatic hypermutation. Single-cell RNA-sequencing identified dramatic increases in B-cell germinal center formation after PD-1 blockade and radiotherapy. Human proteome array revealed enhanced IgG and IgM antibody responses in patients who derived clinical benefit but not those with progressive disease after treatment with PD-1 blockade.Conclusions: These findings establish a key role for B cells in patient outcomes and responses to PD-1 blockade in HPV-associated squamous cell carcinomas and demonstrate the need for additional diagnostics and therapeutics targeting B cells.

28 February 2024 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
SSSarek Shen
Sarek Shen
CPCarlos A. Perez-Heydrich
Carlos A. Perez-Heydrich
DXDeborah X. Xie
Deborah X. Xie
JNJason C. Nellis
Jason C. Nellis

1 June 2019 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
BPBhavik H. Patel
Bhavik H. Patel
KOKelechi R. Okoroha
Kelechi R. Okoroha
TJToufic R. Jildeh
Toufic R. Jildeh
YLYining Lu
Yining Lu
AIAlexander J. Idarraga
Alexander J. Idarraga
BFBrian Forsythe
Brian Forsythe
The effect of concussions on professional athletes has been investigated in many sports. However, few studies have evaluated concussions in National Basketball Association (NBA) players. We hypothesized that concussion incidence has increased, yet the return-to-play (RTP) rate will remain high following the institution of the NBA concussion policy (NBACP). We also hypothesized that the incidence of repeat concussions will be similar to first occurrences and that player performance and game availability will not be significantly affected by sustaining a concussion. Descriptive epidemiology study. Publicly available records were searched to identify all concussions from NBA seasons 1999-2000 to 2017-2018. Player demographics and information regarding career history were tabulated. Incidence of concussion and RTP timing were evaluated before and after institution of the NBACP (2011). Minutes per game and game score per minute were evaluated pre- versus postconcussion. Player availability and performance were also compared with an age-, body mass index–, position-, and experience-matched control group of players who did not sustain a concussion. A total of 189 concussions were reported in the NBA from 1999 to 2018, with a mean ± SD incidence of 9.7 ± 7.3 concussions per season. Following implementation of the NBACP, incidence significantly increased from 5.7 ± 2.8 to 16.7 ± 7.5 concussions per season (P = .007). All players returned to play following first-time concussion after missing 7.7 ± 8.6 days and 3.5 ± 4.1 games. RTP time was not significantly different after implementation of the NBACP (games missed, P = .24; days missed, P = .27), and there was no difference in concussion-free time interval (P = .29). Game score per minute and minutes per game were not significantly affected by sustaining a concussion (both P > .05). Concussion incidence in NBA players is approximately 17 instances per season since the 2011 institution of a league-wide concussion policy. The number of reported concussions significantly increased following the policy, in line with trends seen in other professional sports leagues. Players have retained a high rate of RTP after 3 to 4 missed games. Player performance and availability are not affected by sustaining a concussion following successful RTP.

31 May 2018 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
AJAria Jafari
Aria Jafari
SSSarek Shen
Sarek Shen
DBDavid J. Bracken
David J. Bracken
JPJohn Pang
John Pang
ADAdam S. DeConde
Adam S. DeConde

17 May 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
SSSarek Shen
Sarek Shen
AJAria Jafari
Aria Jafari
JQJesse R. Qualliotine
Jesse R. Qualliotine
ADAdam S. DeConde
Adam S. DeConde

11 February 2020 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
PDF file
SSSarek Shen
Sarek Shen
YSYuki Saito
Yuki Saito
SRShuling Ren
Shuling Ren
CLChao Liu
Chao Liu
TGTheresa Guo
Theresa Guo
JCJoseph A. Califano
Joseph A. Califano
Objective: The incidence and survivorship of human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma (OPSCC) are increasing. Presence of HPV DNA and epigenetic alterations in salivary rinses are independently associated with clinical prognosis. We evaluated the utility of a combined panel in detecting disease recurrence during surveillance. We also assessed the assay’s applicability in screening for HPV+ OPSCC.Study Design: Retrospective cohort study.Setting: Two tertiary academic hospitals.Subjects and Methods: Forty‐nine patients with posttreatment OPSCC were enrolled. Separately, 21 treatment‐naive patients and 40 controls were included in the screening analysis. Salivary rinses were obtained from these cohorts and biomarker levels were quantified. Receiver operative characteristic (ROC) curves and multivariate logistic models were used to assess performance of biomarker combinations.Results: Eight patients (16.3%) in the posttreatment cohort developed locoregional recurrence. Recurrence was associated with alcohol use (odds ratio [OR], 6.12; 95% confidence interval [CI], 0.26‐3.79) and advanced nodal disease (OR, 2.21; 95% CI, 1.52‐3.01). A panel of HPV DNA and methylated EDNRB improved detection of recurrent disease (area under the curve [AUC], 0.88) compared to single markers (AUC, 0.69‐0.78). Positive biomarkers preceded clinical detection by 2.4 ± 1.6 months and was associated with nearly 40‐fold risk of recurrence (OR, 36.4; 95% CI, 1.15‐45.22). Within the screening analysis, single biomarkers demonstrated moderate sensitivity and specificity (AUC, 0.59‐0.83) in the detection of primary disease. A panel combining HPV DNA markers with methylated EDNRB and methylated PAX5 improved AUC to 0.93.Conclusion: Detection of high‐risk HPV DNA or aberrant hypermethylation in oral rinses is associated with presence and recurrence of OPSCC. Targeting both markers in saliva may have utility in long‐term surveillance.